Twenty-four genetically obese and 24 lean barrows were allotted within genotype to either a 16% CP corn-soybean meal basal diet, the basal + .69 ppm cimaterol or the basal + 1.38 ppm cimaterol. Pigs had ad libitum access to their diets from 59.3 kg to 104.5 kg body weight. No genotype x cimaterol interactions were detected (P > .05). Neither genotype nor cimaterol supplementation had any effect (P > .05) on average daily weight gain or gain-to-feed ratio. Compared with lean pigs, obese pigs had higher fasting plasma urea nitrogen (BUN), a smaller gastrointestinal tract and a greater dressing percentage with a shorter and fatter carcass (P < .05). Cimaterol produced a higher fasting plasma BUN, a greater dressing percentage with a leaner carcass and a higher shear force value for loin chops (P c .05). Cimaterol also tended (P < .lo) to increase heart weight. However, no difference was observed in these measurements between pigs fed .69 or 1.38 pprn cimaterol. In lean pigs fed the basal or .69 ppm cimaterol diet, there was no difference (P > .05) in the 8 to 24 h postprandial whole-animal heat production. Cimaterol effectively decreased fat deposition and increased lean accretion both in genetically obese and in lean pigs; there were no differential responses to cimaterol in pigs with different propensities to deposit body fat. 
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Introduction
Although significant improvement in the quality of pork carcass has been made in the last 30 yr, the average contemporary meat-type pig still contains more than 30% fat in its carcass (Topel, 1987) . Recently, a betaadrenergic agonist, cimaterol, has been shown to decrease fat deposition and increase muscle accretion in finishing pigs by partitioning dietary nutrients preferentially toward lean and away from fat tissue (Dalrymple et al., 1984; Jones et al., 1985; Prince et al., 1985; Moser et al., 1986; Cromwell et al., 1988; Walker et al., 1989) . Little is known about the nutrient partitioning effect of cimaterol on genetically obese swine. Differential response to cimaterol has been observed in unselected control mice and those selected for rapid postweaning gain with moderate obesity (Eisen et al., 1988) . No information is available regarding the effect of cimaterol on whole-animal thermogenic activity in pigs. Walker and Romsos (1988) found that cimaterol stimulated wholeanimal 0 2 consumption in both genetically obese and lean mice.
The present study was conducted to determine 1) whether cimaterol would decrease fat deposition and increase muscle accretion and, thus, improve the carcass quality in genetically obese pigs, 2) whether differential responses to cimaterol exist between genetically obese and lean pigs and 3) whether cimaterol would alter whole-animal thermogenic activity in pigs.
Materlals and Methods
Our experiment was conducted during Apnl through July of 1987. Twenty-four genetically obese and 24 genetically lean finishing barrows (59.3 kg average initial weight) were used in a 2 x 3 factorial arrangement with two genotypes and three dietary treatments. The obese and lean pigs were formed from Duroc obese x Yorkshire obese and Duroc lean x Yorkshire lean pigs, respectively, derived from populations selected solely for high or low backfat thickness over multiple generations (Hetzer and Harvey, 1967) . Within genotype, pigs were assigned randomly on the basis of litter to 1) a basal diet, 2) the basal diet with .69 ppm cimaterol added, or 3) the basal diet with 1.38 ppm cimaterol added. The basal diet (Table 1 ) was a 16% CP corn-soybean meal diet fortified with minerals and vitamins to meet or exceed NRC (1979) requirements.
The pigs were housed in individual pens (1.22 x 1.22 m) equipped with feeders and automatic nipple waterers in an enclosed, temperaturecontrolled, slotted-floor building. They were weighed at the beginning of the test and then every 14 d until they reached approximately 100 kg weight. The pigs were fasted for 24 h before they were weighed. At each weighing time, a blood sample was taken from anterior vena cava with a heparinized syringe. Plasma was obtained by centrifugation within 30 min after blood sampling and stored 'Gilford Glucose (Em) at 4°C. It was analyzed, within 8 h after sampling, for glucose7 using hexokinase and glucose-6-phosphate dehydrogenase and for plasma urea nitrogen (BUN)8 using urease and glutamate dehydrogenase. The remaining plasma was stored at -15°C until it was analyzed for triglyceride9 using lipase, glycerol dehydrogenase and diaphorase and for nonesterified fatty acids (NEFA) by extraction and titration (Kelly, 1965) . Except for the 24-h fasting period before each weighing, the pigs had feed at all times. The feed consumption of pigs was recorded every 14 d and before slaughter. Due to the unexpected breakdown of two of our three calorimeters, whole-animal 0 2 consumption and CO, production measurements were conducted only in lean pigs fed the basal diet or the .69 ppm cimaterol diet. When those pigs reached 100 kg, they were weighed, transferred and placed into individual opencircuit indirect calorimeters at 0730. The 16-h 0 2 consumption and CO2 production of the pigs during the 8 to 24 h postprandial period were measured as reported previously (Nienaber and Maddy, 1985) . Following heat production measurement, the pigs were killed by electric stunning and exsanguination. At the time of slaughter, the pigs had been fasted for 24 h. For obese pigs and those lean pigs fed 1.38 ppm cimaterol, no heat production measurement was conducted. Those pigs were fasted for 24 h and then killed. After electric stunning and exsanguination, the pigs were dehaired.
The fresh weights of the heart, liver, spleen, kidney, leaf fat and empty gastrointestinal tract were recorded. The gastrointestinal tract was separated into stomach, small intestine, cecum and colon + rectum. Stomach, cecum and colon + rectum were cut open, rinsed in tap water to remove the contents, blotted dry and weighed. Small intestinal contents were re moved by manual stripping and the empty small intestine was weighed. The carcasses were chilled at 5°C for 2 to 3 d and weighed; then the left half of the carcass was used to measure carcass length (fist rib to aitch bone) and backfat thickness at first rib, last rib and last lumbar vertebra. At the 10th-11th rib interface, longissimus muscle area, fat depth at three-quarters of the lateral distance over the longissimus muscle and fat area bounded by the skin, vertebral column and top of longissimus muscle were measured The untrimmed cuts of Boston butt, picnic, ham, loin (with fat back intact) and belly were obtained from the half-carcass. The four lean cuts were trimmed to have a fat thickness of approxhately .63 cm. The ham was further separated into lean, fat and bone. A portion of trimmed loin was frozen until it was tested later for cooking loss and Warner-Bratzler shear force. Chops (2.5 cm thick) were handcut from the loins after 24 h thawing at 4'C and broiled to an endpoint temperature of 75'C. The weights of loin chops were recorded in thawed and cooked states and cooking loss was computed. Following 24 h of cooling at 4 'C, cores (1.27 cm in diameter) of loin chops were removed parallel to the muscle fibers and Warner-Bratzler shear force was measured.
Data were statistically analyzed with GLM procedures of SAS (1985) . For growth and carcass characteristics, individual pig was used as the experimental unit and data were analyzed as a factorial arrangement with genotype and dietary treatment as main effects. orthogonal contrasts were made to evaluate dietary treatments, For repeatedly measured concentrations of fasting plasma constituents, the data were analyzed as a split-plot in time design. The residual mean square was used as the error term to test the time effect and timerelated interactions, Orthogonal contrast comparisons in dietary treatments were made by using pig (genotype x dietary treatment) mean square as the error term. The data for gaseous measurements and heat production from lean pigs were analyzed as a completely randomized design. All mean values presented are least squares means.
Results and Dlscusslon
Differential responses to cimaterol for growth performance (growth rate, feed intake and feed efficiency) and epididymal fat had occurred in mice selected for rapid gain and unselected control @isen et al., 1988). In the present study with pigs, no genotype x cimaterol interactions (P > .05) were detected for growth, carcass traits, ham and loin characteristics, leaf fat and visceral organ weights, and concentrations of fasting plasma BUN, glucose, NEFA and triglyceride. These results indicate that genetically obese and lean pigs responded to cimaterol supplementation in a similar fashion. This lack of a differential response to cimaterol also was observed in obese and lean pigs treated with ractopamine (Yen et al., 1989) . No genotype differential response (P > .lo) to ractopamine for growth and carcass traits was reported by Bark et al. (1989) in pigs with a low or high capacity for lean tissue (LT) growth. However, unlike the study by Yen et al. (1989) that showed a similar effect (P > .05) of ractopamine on estimated carcass muscle mass in obese and lean pigs, Bark et al. (1989) observed a tendency (P < .lo) for ractopamine to improve carcass muscle mass and lean tissue accretion to a greater degree in pigs with high rather than with low LT growth capacity.
Because there were no genotype x cimaterol interactions, data of simple effects of cimaterol within genotype are presented. As shown in Table 2 , when pigs were allowed ad libitum access to feed in individual pens from 59.3 kg until they were slaughtered at 104.5 kg average weight, there were no differences (P > .05) between the obese and lean pigs in ADG, daily feed intake and gain-to-feed ratio. Dietary supplementation of .69 or 1.38 ppm cimaterol did not affect ADG, daily feed intake or gainto-feed ratio of the obese and lean pigs. Variable results, including positive, negative or no improvement in ADG, feed intake and the efficiency of feed utilization from feeding up to 1 ppm cimaterol, have been observed in other studies with contemporary meat-type finishing pigs (Dalrymple et al., 1984; Jones et al., 1985; Prince et al., 1985; Moser et al., 1986; Cromwell et al., 1988; Walker et al., 1989 for the two levels) tended (P < .lo) to have greater one-half carcass weight and percentage of ham with lower ham fat. However, cimaterol-fed pigs had higher (P < .05) percentages of ham lean and trimmed loin but similar (P > .05) percentages of ham bone and loin. Supplementation of cimaterol also produced greater (P < .05) shear force value but did not alter (P > .05) cooking loss in loin chops. There was no difference (P > .05) in shear force value between pigs fed .69 or 1.38 ppm cimaterol. The differences between the genetically obese and lean pigs in carcass traits and characteristics of ham and loin as observed in the present study are in agreement with previous reports on the same strains of obese and lean pigs (Pond et al., 1980; Pekas et al., 1983; Yen and Pond, 1985; Yen et al., 1989) . The reduction in carcass fatness and increase in lean mass from feeding .69 or 1.38 ppm cimaterol to the genetically obese and lean pigs as found in the present study also agree with those observed in contemporary meattype pigs (Dalrymple et al., 1984; Jones et al., 1985; Prince et al., 1985; Moser et al., 1986; Cromwell et al., 1988; Walker et al., 1989) . The greater shear force value in loin chops of pigs fed cimaterol shown in the present study also has been observed in contemporary pigs receiving .5 (Walker et al., 1989 ) or 1.0 ppm cimaterol (Jones et al., 1985) .
There were differences (P < .05) between obese and lean pigs in the weights of leaf fat, heart, spleen, kidney, stomach, small intestine, cecum, and colon + rectum (Table 5) . However, the weight of liver was similar (P > .05) between obese and lean pigs. Differences in the weight of heart, spleen, stomach and colon + rectum between the obese and lean pigs have been observed previously (Pekas et al., 1983) . In both obese and lean pigs, supplemental cimaterol tended (P = .07) to reduce heart weight but had no effect (P > .05) on the weights of leaf fat, liver, spleen, kidney and gastrointestinal tract. In contemporary pigs, reduced heart weight was observed by Jones et al. (1985) in animals receiving 1 ppm cimater-01, but not by Cromwell et al. (1988) and Qifference between 0 vs .69 and 1.38 ppm cimaterol (P < .lo). Walker et al. (1989) in those receiving .5 ppm cimaterol. Leaf fat weight was not altered by the addition of cimaterol in contemporary pigs by Jones et al. (1985) , Moser et al. (1986) and Walker et al. (1989) , whereas Cromwell et al. (1988) observed a reduction in leaf fat by feeding cimaterol.
Fasting plasma BUN concentration rose (P < .05) over the 8-wk sampling period ( Figure   1 ). In agreement with a previous study (Mersmann et al., 1984) , obese pigs had higher (P < .05) plasma BUN concentration than did lean pigs. The BUN concentration also was higher (P e .05) in pigs fed cimaterolsupplemented diets. However, there was no difference (P > .05) in plasma BUN concentration between pigs fed .69 or 1.38 ppm cimaterol. Because obese pigs have lower muscle accretion capacity, they require less dietary amino acid than do lean pigs. The amino acid contents of the 16% CP diet clearly exceed obese pigs' requirements and, thus, produced a higher plasma BUN concentration. It is not clear why cimaterol increased BUN in both obese and lean pigs. On the basis of increased carcass leanness, pigs fed cimaterol should have higher amino acid requirements, leaving fewer excess amino acids for deamination and urea synthesis.
The least squares mean fasting plasma glucose concentrations were similar for obese and lean pigs (93.9 f .9 and 93.7 f .9 mg/dl, respectively). However, the fasting plasma NEFA was lower (P < .05) for obese than for lean pigs (864 f 25 vs 959 f 24 peqhter), whereas the fasting plasma triglyceride was higher (P e .05) for obese than for lean pigs (86 f 3 vs 74 f 3 mg/dl). These results are in agreement with previous reports (F' ekas et al., 1983; Mersmann and MacNeil, 1985) . Supplementation of cimaterol had no effect on fasting plasma glucose, NEFA or triglyceride of pigs. For pigs fed 0, .69 and 1.38 ppm cimaterol, respectively, the overall least squares means were 96 f 1, 92 f 1 and 93 f 1 mg/d for fasting plasma glucose, 987 f 30, 925 f 30 and 913 f 30 peqhter for fasting plasma NEFA and 82 f 3.80 f 3 and 78 f 3 mg/d for fasting plasma triglyceride. The SD for fasting plasma glucose, NEFA and triglycerides were 10.0 mg/dl, 270 peq/liter and 28 mg/dl, respectively. In lambs fed 10 pprn cimaterol for 6 or 12 wk, plasma glucose was unchanged but plasma NEFA was increased (Beermann et al., 1987) . This increase in NEFA with cimaterol was augmented by fasting the lambs.
In nonruminants, the energy cost and heat production associated with the deposition of protein (7.4 kcal/g; Kielanowski, 1976 about twice that for fat (3.8 kcal/g; Webster, 1977) . It is not known whether whole-animal heat production in pigs is altered by cimaterol as a result of changes in body fat and protein deposition. Due to the limitation of the calorimeter, only lean pigs fed basal or .69 ppm cimaterol diet were used for fasting heat production measurement during the 8 to 24 h postprandial period. As shown in Table 6 , there were no differences (P > .05) between lean pigs fed basal or cimaterol supplemented diet in the whole-animal oxygen consumption, C02 production, heat production or respiratory quotient. These results indicate that cimaterol has little or no thermogenic effect on pigs despite marked changes in carcass leanness. In lambs fed .5 ppm cimaterol, no long-term thermogenic response was observed by Rik- hardsson et al. (1988) . However. increased whole-animal 0 2 consumption was detected in both genetically obese and lean mice when cimaterol was added to the diets for 3 or 9 wk (Walker and Romsos, 1988) .
In conclusion, cimaterol at a level of .69 or 1.38 ppm effectively reduced fat deposition and increased lean accretion, and thus improved carcass leanness both in genetically obese and in lean finishing barrows. There were no difFerential responses to cimaterol between those obese and lean pigs in terms of growth pedormance, carcass traits, ham and loin characteristics, leaf fat and visceral organ weights and selected fasting plasma constituents. Therefore, cimaterol may have a similar effect on pigs having different propensities to deposit body fat. Furthermore, the results with lean pigs on fasting heat production would suggest that the effect of cimaterol on carcass leanness does not increase whole-animal thermogenesis. h e a t production = 3.866 x oxygen consumption + 1.200 X CO2 production.
implications
Cimaterol is a synthetic compound with a chemical structure similar to that of norepinephrine. Cimaterol effectively decreased fat deposition and increased lean accretion and, thus, improved carcass leanness in pigs with different propensities for depositing body fat.
